Thursday, March 5, 2026 3/5/2026

Systemic Cell Senescence as a Mediator of Brain Aging Through Circulation

Award Number: R01AG071686
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2021
PERIOD OF PERFORMANCE END DATE: 07/31/2026

Group Awards By:

View Award Description

Systemic Cell Senescence as a Mediator of Brain Aging Through Circulation - PROJECT SUMMARY Aging is the strongest risk factor for cognitive decline and dementia. Targeting fundamental aging mechanisms offers promising new strategies to counter brain dysfunction. Recent breakthroughs have demonstrated that proteins in aged blood circulation mechanistically contribute to accelerated brain aging, and senescent cells (SCs) accumulate in aging and may drive tissue deterioration, in part, through the proinflammatory senescence associated secretory phenotype (SASP). This research is designed to test whether progeronic SASP proteins produced by systemic SCs mechanistically contribute to accelerated brain aging through blood circulation. This premise is based on published findings establishing that aged blood circulation and/or direct administration of progeronic plasma proteins that are putative SASP factors are sufficient to transfer an accelerated aging phenotype to young mouse brain and our research demonstrating that systemic SC clearance attenuates the SASP in circulation, which is associated with improvements in brain inflammatory parameters and cognitive decline. To test our central hypothesis, we will combine circulatory exchange methods with mouse models in which SCs can be eliminated or production of the SC proteome can be precisely monitored, which will enable us to study whether reducing the circulating SASP is sufficient to ameliorate the adverse influence of aged blood on brain homeostasis. We will develop an innovative transgenic mouse model that will enable bioorthogonal labeling of the nascent p16+ SC proteome. This will empower our discovery of the age- and tissue-specific p16+SC-proteome, its contribution to the circulating progeronic proteome, and its responsivity to SC clearance. Administration of bioorthogonally labeled aged plasma +/- SC clearance to young mice will facilitate discovery of candidate SASP proteins responsible for accelerated aging brain phenotypes for further mechanistic interrogation. Modifying aged blood composition and targeting SCs are therapeutics actively being pursued for ameliorating age-related decline. This project is designed to mechanistically synergize and advance these two promising concepts. Our research may preclinically implicate systemic SC clearance as an option to deplete the progeronic influence of aged blood, ultimately revealing a novel approach for treatment or prevention of age-dependent cognitive decline and dementia.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	5	12/3/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $467,045 )
2025	2025	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	001	5	8/11/2025	NON-COMPETING CONTINUATION	$38,127
2025	2025	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	5	1/15/2025	NON-COMPETING CONTINUATION	$428,918
														Subtotal = $467,045

Issue Date FY: 2024 ( Subtotal = $476,576 )
2024	2024	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	001	4	7/1/2024	NON-COMPETING CONTINUATION	$47,658
2024	2024	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	4	2/12/2024	NON-COMPETING CONTINUATION	$428,918
														Subtotal = $476,576

Issue Date FY: 2023 ( Subtotal = $476,576 )
2023	2023	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	3	1/18/2023	NON-COMPETING CONTINUATION	$476,576
														Subtotal = $476,576

Issue Date FY: 2022 ( Subtotal = $476,576 )
2022	2022	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	001	2	5/10/2022	NON-COMPETING CONTINUATION	$47,659
2022	2022	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	2	2/16/2022	NON-COMPETING CONTINUATION	$428,917
														Subtotal = $476,576

Issue Date FY: 2021 ( Subtotal = $476,576 )
2021	2021	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Aging Research	000	1	4/16/2021	NEW	$476,576
														Subtotal = $476,576

Grand Total All Awards = $2,373,349

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Systemic Cell Senescence as a Mediator of Brain Aging Through Circulation

Award Number: R01AG071686

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2021

PERIOD OF PERFORMANCE END DATE: 07/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer